EP 0690710 A1 19960110 - USE OF CIS-9-HEPTADECENOIC ACID FOR TREATING PSORIASIS, ALLERGIES AND AUTOIMMUNE DISEASES
Title (en)
USE OF CIS-9-HEPTADECENOIC ACID FOR TREATING PSORIASIS, ALLERGIES AND AUTOIMMUNE DISEASES
Title (de)
VERWENDUNG VON CIS-9-HEPTADECENSÄURE ZUR BEHANDLUNG VON PSORIASIS, ALLERGIEN UND AUTOIMMUNERKRANKUNGEN
Title (fr)
UTILISATION D'ACIDE CIS-9-HEPTADECENIQUE POUR LE TRAITEMENT DU PSORIASIS, D'ALLERGIES ET DE MALADIES AUTOIMMUNES
Publication
Application
Priority
- DE 4309512 A 19930325
- EP 9400941 W 19940324
Abstract (en)
[origin: US5708028A] PCT No. PCT/EP94/00941 Sec. 371 Date Sep. 20, 1995 Sec. 102(e) Date Sep. 20, 1995 PCT Filed Mar. 24, 1994 PCT Pub. No. WO94/21247 PCT Pub. Date Sep. 29, 1994Cis-9-heptadecenoic acid or its salts can be used for the prophylaxis and treatment of psoriasis, allergies and autoimmune diseases.
IPC 1-7
IPC 8 full level
A61K 8/30 (2006.01); A61K 8/36 (2006.01); A61K 31/20 (2006.01); A61K 31/201 (2006.01); A61P 17/00 (2006.01); A61P 37/00 (2006.01); A61P 37/08 (2006.01)
CPC (source: EP US)
A61K 31/20 (2013.01 - EP US); A61K 31/201 (2013.01 - EP US); A61P 17/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP)
Citation (search report)
See references of WO 9421247A1
Designated contracting state (EPC)
AT BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
US 5708028 A 19980113; DE 4309512 A1 19940929; EP 0690710 A1 19960110; JP H08508023 A 19960827; WO 9421247 A1 19940929
DOCDB simple family (application)
US 52559495 A 19950920; DE 4309512 A 19930325; EP 9400941 W 19940324; EP 94912534 A 19940324; JP 52067594 A 19940324